Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Monmouth Junction, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
Ayala Pharmaceuticals, Inc. has filed 1,330 SEC EDGAR filings since 14 Dec 1999

SEC filing history

Showing 351-375 of 1,000 matching filings.

Per page
25
Current page
15
4

4 filing

Filing date
25 Apr 2018
Reporting date
25 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 Apr 2018
Reporting date
23 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
25 Apr 2018
Reporting date
23 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
25 Apr 2018
Reporting date
23 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36138

8-K filing

Filing date
23 Apr 2018
Reporting date
23 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Apr 2018
Reporting date
17 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Apr 2018
Reporting date
29 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Apr 2018
Reporting date
29 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-223851

S-8 filing

Filing date
22 Mar 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36138

8-K filing

Filing date
21 Mar 2018
Reporting date
21 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36138

8-K filing

Filing date
12 Mar 2018
Reporting date
12 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-36138

10-Q filing

Filing date
12 Mar 2018
Reporting date
31 Jan 2018
Next action
Verify source filing
4

4 filing

Filing date
01 Mar 2018
Reporting date
28 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 Mar 2018
Reporting date
28 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-216008

424B5 filing

Filing date
22 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36138

8-K filing

Filing date
22 Feb 2018
Reporting date
22 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-216008

424B5 filing

Filing date
21 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36138

8-K filing

Filing date
21 Feb 2018
Reporting date
21 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36138

8-K filing

Filing date
15 Feb 2018
Reporting date
13 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-80101

ADVAXIS, INC.

Filing date
13 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36138

DEF 14A filing

Filing date
06 Feb 2018
Reporting date
06 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Feb 2018
Reporting date
31 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Feb 2018
Reporting date
31 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Feb 2018
Reporting date
02 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-80101

SC 13G/A filing

Filing date
29 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .